Word

EGENE

Status

Registered

Status Code

700

Status Date

Tuesday, August 1, 2023

Serial Number

97132863

Registration Number

7124080

Registration Date

Tuesday, August 1, 2023

Mark Type

4000

Filing Date

Thursday, November 18, 2021

Published for Opposition

Tuesday, May 16, 2023

Trademark Owner History

NUCLERA LTD - Original Registrant
Nuclera Nucleics Limited - Owner At Publication

Classifications

9 Scientific apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; medical laboratory research instrument in the nature of desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; bio-chips for scientific, research or industrial purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using polymerase chain reaction (PCR); apparatus and instruments for synthesising DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; computer hardware, recorded computer software, downloadable computer software, and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology and medical science

5 Pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use, namely, nucleic acid sequences, genes and proteins; therapeutic DNA and RNA products, namely, nucleic acid sequences, genes and proteins for medical and veterinary purposes; vaccines; all for expression of proteins and none being mutation detection reagents, genome editing reagents, or polynucleotide assembly reagents

1 Nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides and synthetic proteins for scientific and industrial use; all for expression of proteins and none being mutation detection reagents, genome editing reagents, or polynucleotide assembly reagents

10 Apparatus and instruments for DNA, RNA, gene and protein synthesis for medical and veterinary purposes

Trademark Events

Aug 1, 2023

Notice Of Registration Confirmation Emailed

Aug 1, 2023

Registered-Principal Register

Jun 14, 2023

Automatic Update Of Assignment Of Ownership

May 16, 2023

Official Gazette Publication Confirmation E-Mailed

May 16, 2023

Published For Opposition

Apr 26, 2023

Notification Of Notice Of Publication E-Mailed

Apr 13, 2023

Approved For Pub - Principal Register

Apr 13, 2023

Examiner's Amendment Entered

Apr 13, 2023

Notification Of Examiners Amendment E-Mailed

Apr 13, 2023

Examiners Amendment E-Mailed

Apr 13, 2023

Examiners Amendment -Written

Apr 11, 2023

Teas/Email Correspondence Entered

Apr 11, 2023

Correspondence Received In Law Office

Apr 11, 2023

Assigned To Lie

Mar 30, 2023

Preliminary/Voluntary Amendment - Entered

Mar 30, 2023

Teas Voluntary Amendment Received

Feb 27, 2023

Teas Response To Office Action Received

Aug 31, 2022

Notification Of Non-Final Action E-Mailed

Aug 31, 2022

Non-Final Action E-Mailed

Aug 31, 2022

Non-Final Action Written

Aug 30, 2022

Assigned To Examiner

Nov 23, 2021

New Application Office Supplied Data Entered

Nov 22, 2021

New Application Entered